Middle East and Africa Skin Graft Market

Market Introduction

Middle East and Africa skin graft market is analyzed based countries such as Saudi Arabia, UAE, South Africa, and Rest of Middle East and Africa. The UAE is accounting for the largest market share in the region. The growth can be attributed to increasing government favorable policies in countries such as Saudi Arabia and the UAE. The countries are developing their healthcare facilities and increasing partnerships with foreign entities are likely to grow the market during the forecast period. The growth of skin graft market is the UAE is driven by, focus on cancer awareness through various initiatives by the government authorities. According to the Department of Health UAE, cancer is the third leading cause of death. In 2020, there were nearly 1896 deaths caused by cancer. As per the World Health Organization (WHO), incidence of cancer in the Middle East including UAE is on rise.  Drastic changes in lifestyle, increasing number of outdoor activities and rising use of artificial tanning solutions are major risk factors of skin cancer among the people in the UAE. Although the prevalence of skin cancer is found to the lower than other types of cancers, its incidence is high among the people with fair skin. A number of campaigns are carried out in the UAE for cancer prevention, diagnosis and treatment. For instance, In March 2018, KickCancer is a campaign initiated by Friends of Cancer Patients, UAE, which aims at a creating awareness about early diagnosis, regular examination and timely treatment. Moreover, as per the HAAD Injury and Poisoning Notification System (IPNS), in UAE, burns are one of the top ten injuries

Countries such as UAE, and Saudi Arabia have also registered a significant number of positive patients. These regions are developing in terms of the medical industry. The countries in these regions are highly dependent on medical devices and pharmaceutical products. Therefore, countries have faced several challenges for their requirements. Initial phase of lockdown in various countries has affected the supply of many instruments in these regions. However, the lockdown has affected the supply chain of various companies in these regions. The increasing numbers of COVID-19 positive patients are becoming threats to their respective countries. The countries are facing economic crises, which have affected various businesses, including the healthcare business. The countries are majorly dependent on the imports for healthcare products. The lockdown in various countries across the world and limited transport and declined the sales of healthcare products across the world. Thus, the above-mentioned factors have to impact the skin graft market negatively.

Middle East and Africa Skin Graft Strategic Insights

Strategic insights for the Middle East and Africa Skin Graft provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Skin Graft Report Scope

Middle East and Africa Skin Graft Regional Insights

The geographic scope of the Middle East and Africa Skin Graft refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Market Overview and Dynamics

The skin graft market in MEA is expected to grow from US$ 84.39 million in 2021 to US$ 117.48 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2021 to 2028. Research activities and product innovations; skin grafts are a major requirement in the wound care industry. However, the availability of a suitable donor is a major concern in skin grafting market. Hence, over the years, researchers have been carrying out R&D activities which have resulted in product innovations. There are several products in the clinical trial phase, which can boost the market of skin grafts in the coming years. In June 2017, Mallinckrodt plc enrolled the first patient in phase 3 trial of StrataGraft regenerative skin tissue. The research activities as well as product innovations are expected to provide impetus for the growth of the skin graft market in the coming years.

 

Key Market Segments

Based on product, the market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2020, the autologous segment held the largest share of the market. Based on graft thickness, the market is divided into split-thickness, full-thickness and composite graft. In 2020, the split thickness segment held the largest share of the market. Based on equipment, the market is segmented into dermatome, general surgical instruments, consumables, and others

.

In 2020, the dermatome segment held the largest share of the market.

Based on application, the market is segmented into burns, extensive wound, skin cancer, and others. In 2020, the burns segment held the largest share of the market

.

Based on end use

r

, the market is segmented into ambulatory surgical centers, hospitals and dermatology clinics. In 2020, the hospitals segment held the largest share of the market.

 

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the skin graft market in MEA are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are B. Braun Melsungen AG; Integra Life Sciences Corporation; MiMedx; Organogenesis Inc; Smith & Nephew; Zimmer Biomet.

 

Reasons to buy report

• To understand the MEA skin graft market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for MEA Skin Graft Market
• Efficiently plan M&A and partnership deals in MEA skin graft market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form MEA skin graft market
• Obtain market revenue forecast for market by various segments from 2021-2028 in MEA region.

 

 

MEA SKIN GRAFT MARKETSEGMENTATION

 

By Product

• Autologous
• Allogeneic
• Xenogeneic
• Prosthetic
• Isogeneic

 

By Graft Thickness

• Split-Thickness
• Full-Thickness
• Composite Graft

 

By Equipment

• Dermatome
• General Surgical Instruments
• Consumables
• Others

 

 By Application

• Burns
• Extensive Wound
• Skin Cancer
• Other Applications

By End User

• Hospitals
• Ambulatory Surgical Centers
• Dermatology Clinics

 

By Country

• UAE
• Saudi
• SA
• RPMEA

Companies Mentioned

• B. Braun Melsungen AG
• Integra Life Sciences Corporation
• MiMedx
• Organogenesis Inc
• Smith & Nephew
• Zimmer Biomet